脓毒症相关急性肾损伤生物标志物的研究进展
脓毒症定义为宿主对感染反应失调所致的危及生命的器官功能障碍,脓毒症相关急性肾损伤(SA-AKI)是其常见器官功能障碍,发病率和病死率不断上升,给患者和社会带来沉重经济负担。早期诊断和有效干预可有效阻断SA-AKI的发生与进展、改善预后并降低医疗费用。目前SA-AKI诊断依赖尿量和血清肌酐,存在易受干扰和滞后的缺点。本文综述了已发现并验证的多种SA-AKI生物标志物特征,包括损伤前标志物、损伤标志物和功能标志物,并探讨血解偶联蛋白2(UCP2)、Sestrin 2蛋白和pannexin 1(PANX1)等新发现生物标志物在SA-AKI诊断与治疗中的临床价值,为早期诊断和有效治疗提供参考。
要点
- SA-AKI诊断目前依赖尿量和血清肌酐,存在易受干扰和滞后的缺点。
- 血和尿中生物标志物的识别可促进诊断并提供靶向治疗,从而加强SA-AKI管理。
- 综述涵盖损伤前标志物、损伤标志物和功能标志物三类已发现并验证的SA-AKI生物标志物。
- 血UCP2、Sestrin 2蛋白和PANX1等新发现生物标志物与SA-AKI诊断和治疗相关,本文探讨其临床价值。
- 早期诊断和有效干预可有效阻断SA-AKI发生与进展、改善预后并降低医疗费用。
适用人群与场景
- 脓毒症患者,SA-AKI为其常见器官功能障碍。
研究设计与关键结果
- 综述总结了已发现并验证的多种SA-AKI生物标志物特征,包括损伤前标志物、损伤标志物和功能标志物。
- 综述探讨了血解偶联蛋白2(UCP2)、Sestrin 2蛋白和pannexin 1(PANX1)等新发现生物标志物与SA-AKI诊断和治疗相关的临床价值。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis-associated acute kidney injury (SA-AKI) is a common organ dysfunction of sepsis, and its incidence and mortality are increasing,which brings heavy economic burden to patients and society. Early diagnosis and effective intervention can block the occurrence and progression of SA-AKI effectively, improve prognosis, and reduce medical costs. Diagnosis on SA-AKI relies on urine volume and serum creatinine, which has the disadvantages of being easily disturbed and delaying. The identification of biomarkers in blood and urine can facilitate diagnosis and provide targeted therapy to enhance the management of SA-AKI. This article reviews the characteristics of a variety of SA-AKI biomarkers that have been found and validated, including pre-damage biomarkers, damage biomarkers and functional biomarkers, and explore the clinical value of newly discovered biomarkers related to the diagnosis and treatment of SA-AKI, such as blood uncoupling protein 2 (UCP2), Sestrin 2 protein and pannexin 1 (PANX1), to provide reference for the early diagnosis and effective treatment of SA-AKI.
参考来源
- Zhang J, Qi M, Ma L, et al. [Research progress on biomarkers of sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39697031. doi:10.3760/cma.j.cn121430-20231018-00883
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。